165 related articles for article (PubMed ID: 35901348)
1. Analysis of Rapid arc-based Radiation Therapy on Dosimetric Parameters in Cervical Cancer Patients with and without Bone Marrow Sparing.
Aggarwal R; Sood S; Singh M; Singh K; Sood D; Mupasana V; Palanisamy M
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2407-2413. PubMed ID: 35901348
[TBL] [Abstract][Full Text] [Related]
2. Comparative Analysis of VMAT and IMRT Techniques: Evaluation of Dose Constraints and Bone Marrow Sparing in Cervical Cancer Patients Undergoing Chemoradiotherapy.
Thakur N; Kaur H; Kaur S; Lehal P; Sudan M; Jain N; Sharma R; Sharma A
Asian Pac J Cancer Prev; 2024 Jan; 25(1):139-144. PubMed ID: 38285777
[TBL] [Abstract][Full Text] [Related]
3. Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer.
Bao Z; Wang D; Chen S; Chen M; Jiang D; Yang C; Liu H; Dai J; Xie C
Radiat Oncol; 2019 Aug; 14(1):118. PubMed ID: 31378200
[TBL] [Abstract][Full Text] [Related]
4. A dosimetric analysis of tomotherapy based intensity modulated radiation therapy with and without bone marrow sparing in gynecologic malignancies.
Platta CS; Bayliss A; McHaffie D; Tome WA; Straub MR; Bradley KA
Technol Cancer Res Treat; 2013 Feb; 12(1):19-29. PubMed ID: 22974331
[TBL] [Abstract][Full Text] [Related]
5. A Dosimetric Analysis of Modified Volumetric Modulated Arc Therapy for Bone Marrow Sparing Radiotherapy in Cervical Cancer-An alternative Approach to Conventional VMAT.
Palani D; Govindaraj K; Sampathrajan S; Karunagaran L; Ganesh KM
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4323-4332. PubMed ID: 36580016
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy - A proton versus photon comparison.
De Ornelas M; Iorio GC; Bossart E; Ricardi U; Seldon C; Dal Pra A; Butkus M
Phys Med; 2023 Aug; 112():102644. PubMed ID: 37487297
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy.
Lujan AE; Mundt AJ; Yamada SD; Rotmensch J; Roeske JC
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):516-21. PubMed ID: 12957265
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of bone marrow sparing volumetric modulated arc therapy to spare active bone marrow in cervical and vaginal cancer patients: a retrospective dosimetric analysis.
Beavan M; Dundas K; Hudson F; Surjan Y; Lau A; Deshpande S; Lim K; Do V
J Med Radiat Sci; 2021 Dec; 68(4):379-388. PubMed ID: 34288534
[TBL] [Abstract][Full Text] [Related]
9. A dosimetric analysis of intensity-modulated radiation therapy with bone marrow sparing for cervical cancer.
Murakami N; Okamoto H; Kasamatsu T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Toita T; Ito Y; Itami J
Anticancer Res; 2014 Sep; 34(9):5091-8. PubMed ID: 25202097
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
[TBL] [Abstract][Full Text] [Related]
11. Pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis.
Zhou P; Zhang Y; Luo S; Zhang S
Radiother Oncol; 2021 Dec; 165():103-118. PubMed ID: 34718055
[TBL] [Abstract][Full Text] [Related]
12. Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy.
Wang Y; Xiao Q; Zeng B; Ni Q; Liu X; Liu X; Tian L; Sheng C; Peng L; Wang H
Med Dosim; 2020 Spring; 45(1):e6-e12. PubMed ID: 31176536
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies.
Liang Y; Bydder M; Yashar CM; Rose BS; Cornell M; Hoh CK; Lawson JD; Einck J; Saenz C; Fanta P; Mundt AJ; Bydder GM; Mell LK
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):406-14. PubMed ID: 22687195
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer.
Li N; Noticewala SS; Williamson CW; Shen H; Sirak I; Tarnawski R; Mahantshetty U; Hoh CK; Moore KL; Mell LK
Radiother Oncol; 2017 May; 123(2):325-330. PubMed ID: 28528206
[TBL] [Abstract][Full Text] [Related]
15. Extended-field bone marrow sparing radiotherapy for primary chemoradiotherapy in cervical cancer patients with para-aortic lymphadenopathy: Volumetric-modulated arc therapy versus helical tomotherapy.
Chen JL; Wang MC; Huang YS; Huang CY; Pan CK; Hsu CY; Lan KH; Kuo SH
J Xray Sci Technol; 2020; 28(1):111-124. PubMed ID: 31904003
[TBL] [Abstract][Full Text] [Related]
16. Which Bone Marrow Sparing Strategy and Radiotherapy Technology Is Most Beneficial in Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Patients With Cervical Cancer?
Yu DY; Bai YL; Feng Y; Wang L; Yun WK; Li X; Song JY; Yang SS; Zhang YY
Front Oncol; 2020; 10():554241. PubMed ID: 33392067
[TBL] [Abstract][Full Text] [Related]
17. Acute hematological toxicity during post-operative bowel sparing image-guided intensity modulated radiation with concurrent cisplatin.
Lewis S; Chopra S; Naga P; Pant S; Dandpani E; Bharadwaj N; Mahantshetty U; Engineer R; Swamidas J; Ghosh J; Gupta S; Shrivastava S
Br J Radiol; 2018 Dec; 91(1092):20180005. PubMed ID: 30179056
[TBL] [Abstract][Full Text] [Related]
18. Relations between doses cumulated in bone marrow and dose delivery techniques during radiation therapy of cervical and endometrial cancer.
Jodda A; Urbański B; Piotrowski T; Malicki J
Phys Med; 2017 Apr; 36():54-59. PubMed ID: 28410686
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparisons of three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy in whole abdominopelvic radiotherapy for gynecologic malignancy.
Kim YB; Kim JH; Jeong KK; Seong J; Suh CO; Kim GE
Technol Cancer Res Treat; 2009 Oct; 8(5):369-77. PubMed ID: 19754213
[TBL] [Abstract][Full Text] [Related]
20. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
